Clinical Chemistry Siemens Point of Care - Urinalysis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 49: 175-178, 2003; 10.1373/49.1.175
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamanishi, H.
Right arrow Articles by Iwatani, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamanishi, H.
Right arrow Articles by Iwatani, Y.
Related Collections
Right arrow Laboratory Management
Right arrow General Clinical Chemistry
Right arrow Proteomics and Protein Markers
Right arrow Drug Monitoring and Toxicology
Right arrow Hematology
(Clinical Chemistry. 2003;49:175-178.)
© 2003 American Association for Clinical Chemistry, Inc.


Technical Briefs

Total Iron-binding Capacity Calculated from Serum Transferrin Concentration or Serum Iron Concentration and Unsaturated Iron-binding Capacity

Hachiro Yamanishi1,2a, Shigeru Iyama1, Yoshihisa Yamaguchi1, Yuzuru Kanakura1 and Yoshinori Iwatani2,3

1 Laboratory for Clinical Investigation, Osaka University Hospital, 2-15, Yamada-oka, Suita, Osaka 565-0871, Japan

2 Division of Laboratory Science, Course of Health Science, Graduate School of Medicine, and
3 Department of Clinical Laboratory Science, School of Allied Health Sciences Faculty of Medicine, Osaka University, 1-7 Yamada-oka, Suita, Osaka 565-0871, Japan

aauthor for correspondence: fax 81-6-6879-6635, e-mail yamaha{at}hp-lab.med.osaka-u.ac.jp

Total iron-binding capacity (TIBC) indicates the maximum amount of iron needed to saturate plasma or serum transferrin (TRF), which is the primary iron-transport protein (1). Theoretically, 1 mol of TRF [average molecular mass, 79 570 Da (2)] can bind 2 mol of iron (55.8 Da) at two high-affinity binding sites for ferric iron (3). Therefore, TIBC correlates well with TRF concentration, and the theoretical ratio of TIBC (in µmol/L) to TRF (in g/L) is 25.1: TIBC (µmol/L) = 25.1 x TRF (g/L) (4)(5).

Measurements of TIBC, serum iron, and the percentage of iron saturation of TRF are useful for the clinical diagnosis of iron-deficiency anemia and chronic inflammatory disorders (6)(7) and as screening tests for other clinical conditions (8). TIBC is routinely determined (9)(10)(11)(12) by saturation of TRF with an excess predetermined amount of iron, removal of the unbound iron, and measurement of the iron that is dissociated from TRF. For removal of the unbound iron, magnesium carbonate (9), ion-exchange resin (10), alumina columns (11), or magnetic particles(12) are used. Most direct TIBC measurement methods require manual procedures that involve centrifugation or pretreatment of serum samples. As an alternative to direct measurement methods, TIBC values are also calculated from the sum of serum iron and unsaturated iron-binding capacity (UIBC), both of which are determined by colorimetric methods (calculation method).

We developed a direct and fully automated TIBC (DTIBC) assay for use with an automated multipurpose analyzer (13)(14). A fully automated TIBC measurement method is also commercially available (15). In our previous study (14), TIBC values obtained by DTIBC assay correlated strongly with serum TRF concentrations (r = 0.984; n = 59), and the slope of the regression line was consistent with the theoretical TIBC/TRF ratio. We also observed good correlation between our DTIBC values and values calculated from the sum of serum iron and UIBC, but the calculated TIBC values were lower than the DTIBC-determined values and TIBC values obtained by an automated assay. Similar results have been reported in a comparison of a calculation method and a direct automated TIBC assay (16). In the present study, we reevaluated the relationships between TRF concentrations and TIBC values obtained by the DTIBC assay and by calculation methods in a large sample (n = 188) and used multiple regression analysis to investigate the difference between TIBC values converted from TRF concentrations and calculated TIBC values.

In addition to TIBC, TRF, serum iron, and UIBC, we measured serum ferritin and ceruloplasmin concentrations in the sera of 188 patients. Ferritin plays important roles in iron metabolism, storage, and detoxification (17). Ceruloplasmin has ferroxidase activity as well as ferritin H subunits, and patients with a congenital absence of ceruloplasmin develop severe iron overload (17)(18). The DTIBC assay was performed with the Hitachi Model 7070 automated analyzer. Both serum iron and UIBC were determined by direct colorimetric methods (Wako Pure Chemical Industries and Roche Diagnostics). The serum iron/UIBC assays from Wako use bathophenanthroline as chromogen, and those from Roche use ferrozine as chromogen. Calibration was with physiologic saline (zero calibrator) and an iron solution (36 µmol/L Fe3+ in 0.9 g/L H2SO4). TIBC was then calculated as the sum of serum iron plus UIBC (CTIBCbatho and CTIBCferro). Serum TRF and ceruloplasmin concentrations were determined by nephelometric assay with the Behring Nephelometer II analyzer (Dade Behring Marburg GmbH). Serum ferritin was measured with the ADVIA Centaur Ferritin Assay Reagent and ADVIA Centaur Analyzer (Bayer Diagnostics).

Shown in Fig. 1 are the correlations between serum TRF concentrations and TIBC determined by DTIBC assay and by the calculation methods (panels A–C) and between the DTIBC assay values and the calculated TIBC values (panels D and E). We found highly significant correlations (P <0.001) between the DTIBC assay values, the calculated TIBC values, and the serum TRF concentrations. The DTIBC and calculated TIBC values also correlated well, but the TIBC calculation method showed a negative difference (slope = 0.87 and 0.88). The mean (SD) TIBC values were as follows: DTIBC, 63.8 (14.7) µmol/L; CTIBCbatho, 56.8 (13.2) µmol/L; and CTIBCferro, 56.4 (13.3) µmol/L. The calculated TIBC values were significantly lower than the DTIBC values (P <0.001) regardless of which chromogen was used in the colorimetric assays. Correlation between the two calculation methods was: CTIBCbatho = 0.994(CTIBCferro) + 0.80 µmol/L (r = 0.999; Sy|x = 0.70 µmol/L). We observed no difference between the CTIBCbatho and the CTIBCferro values.



View larger version (16K):
[in this window]
[in a new window]
 
Figure 1. Correlation between TRF concentrations and TIBC values and between DTIBC assay values and the calculated TIBC values.

(A), TRF (x) vs DTIBC (y): y = 25.7x + 3.3 µmol/L (r = 0.973; Sy|x = 3.4 µmol/L; n = 188). (B), TRF (x) vs CTIBCbatho (y): y = 23.3x + 2.0 µmol/L (r = 0.982; Sy|x = 2.4 µmol/L; n = 188). (C), TRF (x) vs CTIBCferro (y): y = 23.4x + 1.2 µmol/L (r = 0.983; Sy|x = 2.4 µmol/L; n = 188). (D), DTIBC (x) vs CTIBCbatho (y): y = 0.87x + 0.90 µmol/L (r = 0.976; Sy|x = 2.9 µmol/L; n = 188). (E), DTIBC (x) vs CTIBCferro (y): y = 0.88x + 0.16 µmol/L (r = 0.977; Sy|x = 2.8 µmol/L; n = 188). The solid lines are the regression lines. The dashed lines represent y = 25.1x in panels A–C and y = x in panels D and E.

We also calculated the difference between the TIBC values converted from TRF concentrations and the calculated TIBC values [25.1 x TRF (g/L) - CTIBC (µmol/L)] and determined the relationships between the difference and serum concentrations of iron, UIBC, ferritin, and ceruloplasmin by multiple regression analysis. Sex was included as a covariate in the multiple regression models, and all continuous variables were transformed to gaussian distribution. The mean (SD) difference was 2.0 (2.6) µmol/L for CTIBCbatho and 2.4 (2.6) µmol/L for CTIBCferro. As shown in Table 1 , only UIBC had an independent influence on the difference in both models. UIBC was statistically associated with the difference in linear regression analysis. Serum iron was statistically associated with the CTIBCbatho difference in linear regression analysis (P = 0.015); this was not, however, a significant variable in the multiple regression model that included ferritin. When UIBC was calculated as the difference in TIBC determined by DTIBC assay and the amount of serum iron determined by the colorimetric methods (CUIBCbatho and CUIBCferro), the regression equation for the measured UIBC (y) and the CUIBCbatho (x) was: y = 0.90x - 2.4 µmol/L (r = 0.98). The regression equation for CUIBCferro (x) was: y = 0.88x + 0.17 µmol/L (r = 0.97). The UIBC values determined by the colorimetric methods were lower than both of the CUIBC values.


View this table:
[in this window]
[in a new window]
 
Table 1. Multiple regression analysis of the difference between the TIBC converted from TRF and the calculated TIBC.

The slope of the regression line in which the DTIBC values are plotted against the TRF values is consistent with the theoretical TIBC/TRF ratio. However, the slopes of the regression lines for the calculated TIBC values plotted against the TRF values were ~7% lower than the theoretical ratio (Fig. 1Up , B and C). The results of multiple regression analysis suggest that the UIBC is independently associated with an increase in the difference between the converted TIBC and the calculated TIBC. Moreover, the slopes of the regression lines for the calculated UIBC values plotted against the measured UIBC were similar to the slopes of the regression lines in which the DTIBC values were plotted against the calculated TIBC. These results indicate that the differences in the DTIBC and the calculated TIBC can be attributed to the low UIBC value determined by the colorimetric assay. The UIBC concentrations were determined as the differences be-tween a known amount of iron added for saturation of TRF and the amount of iron that was left after binding to unsaturated sites on TRF in the colorimetric UIBC methods. However, the binding of iron to TRF is not instantaneous, it takes many minutes to reach completion. As the number of unsaturated sites increases, more time is required for the reaction to come to completion. The low UIBC result obtained by the automated UIBC method was probably attributable to insufficient time allowed for the saturation of TRF.

Gambino et al. (5) reported that a two-point calibration method with a protein-based calibrator should be used for colorimetric UIBC methods and that this calibration method provides a more accurate calculated TIBC value. Although the availability of the proposed calibration method for the colorimetric UIBC methods was not evaluated in this study, the results of our multiple regression analysis provide support for the conclusions of the study by Gambino et al. (5). We anticipated that ferritin and ceruloplasmin, which are iron-related proteins, would be associated with the difference between methods, but the results of our multiple regression analysis showed that these factors did not account for a significant variance in the difference. However, ferritin may be a confounding factor in the difference between the converted TIBC and the calculated TIBC. For calculation of an accurate TIBC value from the sum of serum iron and UIBC, it is likely that a multipoint calibration method with human protein-based calibrators for colorimetric UIBC assays will be useful. However, the total amount of iron that is really bound to TRF iron-binding sites should probably be measured as TIBC. When the slope of the regression line for calculated TIBC values plotted against TRF concentrations is significantly lower than the theoretical TIBC/TRF ratio, UIBC should be computed as the differences between TIBC measured by a direct TIBC method and serum iron. With the calculation method, when either the serum iron concentration or UIBC value is below detectable limits, TIBC cannot be determined.

In conclusion, TIBC values determined by DTIBC assay were strongly correlated with TRF concentrations. The slope of the regression line for the DTIBC values plotted against the TRF is consistent with the theoretical TIBC/TRF ratio. TIBC values calculated from the sum of serum iron and UIBC were significantly lower than those obtained by the DTIBC assay. This can be attributed to underestimation of UIBC values by the colorimetric assay. UIBC is an independent factor that influences the difference between the converted TIBC values and the calculated TIBC values. We suggest that TIBC be measured by direct TIBC methods and that UIBC be calculated as the difference between TIBC and serum iron.


References

  1. Aisen P, Leibman A, Reich HA. Studies on the binding of iron to transferrin and conalbumin. J Biol Chem 1966;241:1666-1671.[Abstract/Free Full Text]
  2. De Jong G, Van Dijk JP, Van Eijk HG. The biology of transferrin. Clin Chim Acta 1990;190:1-46.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  3. Baker EN, Lindley PF. New perspectives on the structure and function of transferrin. J Inorg Biochem 1992;47:147-160.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  4. Vernet M. Immunochemical assay of transferrin and iron saturation in serum. Clin Chem 1993;39:2352-2353.[Web of Science][Medline] [Order article via Infotrieve]
  5. Gambino R, Desvarieux E, Orth M, Matan H, Ackattupathil T, Lijoi E, et al. The relationship between chemically measured total iron-binding capacity concentrations and immunologically measured transferrin concentrations in human serum. Clin Chem 1997;43:2408-2412.[Abstract/Free Full Text]
  6. Fairbanks VF, Klee GG. Biochemical aspects of hematology. Burtis CA Ashwood ER eds. Tietz textbook of clinical chemistry, 2nd ed 1994:1974-2072 WB Saunders Philadelphia. .
  7. Huebers HA, Eng MJ, Josephson BM, Ekpoom N, Rettmer RL, Labbé RF, et al. Plasma iron and transferrin iron-binding capacity evaluated by colorimetric and immunoprecipitation method. Clin Chem 1987;33:273-277.[Abstract/Free Full Text]
  8. Brittenham GM, Danish EH, Harris JW. Assessment of bone marrow and body iron stores: old techniques and new technologies. Semin Hematol 1981;18:194-221.[Web of Science][Medline] [Order article via Infotrieve]
  9. . National Committee for Clinical Laboratory Standards. Determination of serum iron and total iron binding capacity; proposed standard. NCCLS document H17-P, Vol. 10, No. 4 1990 NCCLS Wayne, PA. .
  10. Henry RJ. Clinical chemistry, principles and technics, 1st ed 1964:391-395 Harper & Row New York. .
  11. Starr R. Use of an alumina column in estimating total iron-binding capacity. Clin Chem 1980;26:156-158.[Abstract/Free Full Text]
  12. Siek G, Lawlor J, Pelczar D, Sane R. Development and performance characteristics of a magnetic separation based TIBC [Abstract]. Clin Chem 1999;45:A167-A168.
  13. Yamanishi H, Kimura S, Iyama S, Yamaguchi Y, Yanagihara T. Fully automated measurement of total iron-binding capacity in serum. Clin Chem 1997;43:2413-2417.[Abstract/Free Full Text]
  14. Yamanishi H, Iyama S, Yamaguchi Y, Kanakura Y, Iwatani Y. Modification of fully automated total iron-binding capacity (TIBC) assay in serum and comparison with Dimension TIBC method. Clin Chem 2002;48:1565-1570.[Abstract/Free Full Text]
  15. Yue Y, Arana C, Staples M. Development of a fully automated TIBC method for the Dimension® clinical chemistry system [Abstract]. Clin Chem 2000;46:A146.
  16. Siek G, Lawlor J, Pelczar D, Sane M, Musto J. Direct serum total iron-binding capacity assay suitable for automated analyzers. Clin Chem 2002;48:161-166.[Abstract/Free Full Text]
  17. Harrison PM, Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochem Biophys Acta 1996;1275:161-203.[Medline] [Order article via Infotrieve]
  18. Morita H, Ikeda S, Yamamoto K, Morita S, Yoshida K, Nomoto S, et al. Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family. Ann Neurol 1995;37:646-656.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]



The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
H. Yamanishi, S. Iyama, Y. Yamaguchi, Y. Kanakura, and Y. Iwatani
Modification of the Colorimetric Assay for Serum Unsaturated Iron-binding Capacity
Clin. Chem., June 1, 2003; 49(6): 1023 - 1025.
[Full Text] [PDF]


This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamanishi, H.
Right arrow Articles by Iwatani, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamanishi, H.
Right arrow Articles by Iwatani, Y.
Related Collections
Right arrow Laboratory Management
Right arrow General Clinical Chemistry
Right arrow Proteomics and Protein Markers
Right arrow Drug Monitoring and Toxicology
Right arrow Hematology


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS